|
|
Effects of angiotensin II AT1-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in dahl salt-sensitive rats
|
|
|
|
|
نویسنده
|
kosaka s. ,pelisch n. ,rahman m. ,nakano d. ,hitomi h. ,kobori h. ,fukuoka n. ,kobara h. ,mori h. ,masaki t. ,cervenka l. ,matsumura y. ,houchi h. ,nishiyama a.
|
منبع
|
journal of pharmacological sciences - 2013 - دوره : 121 - شماره : 2 - صفحه:95 -102
|
چکیده
|
We examined the effects of angiotensin ii at1-receptor blockade with olmesartan on high fat (hf) diet-induced vascular oxidative stress and endothelial dysfunction in normal salt (ns) diet-fed dahl salt-sensitive (dss) rats. treatment with ns + hf diet (32% crude fat,0.3% nacl) for 20 weeks significantly increased blood pressure in dss rats. ns + hf diet-fed dss rats also showed higher plasma levels of thiobarbituric acid-reactive substances,aortic superoxide production,and mrna levels of p22phox and gp91phox in aortic tissues than ns diet-fed dss rats. furthermore,acetylcholine-induced vasorelaxation of aorta from ns + hf diet-fed dss rats was significantly reduced. in ns + hf diet-fed dss rats,treatment with olmesartan medoxomil (10 mg/kg per day,p.o.) and hydralazine (25 mg/kg per day,p.o.) similarly decreased blood pressure. however,in these animals,only olmesartan normalized plasma levels of thiobarbituric acid- reactive substances,vascular superoxide in aortic tissues,and acetylcholine-induced vasorelaxation. these data indicate that hf diet-induced hypertension is associated with vascular oxidative stress and endothelial dysfunction in ns diet-treated dss rats. inhibition of angiotensin ii at1 receptors may elicit beneficial effects on hf-induced hypertension and vascular injury in subjects that have genetically enhanced sodium-sensitive blood pressure. © the japanese pharmacological society.
|
کلیدواژه
|
Angiotensin II (AngII); Dahl salt-sensitive (DSS) rat; Endothelial dysfunction; High fat (HF) diet; Oxidative stress
|
آدرس
|
department of pharmacology,kagawa university medical school,kagawa 761-0793,japan,department of pharmacy,kagawa university hospital,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan, department of pharmacy,kagawa university hospital,kagawa 761-0793, Japan, department of gastroenterology,kagawa university medical school,kagawa 761-0793, Japan, department of gastroenterology,kagawa university medical school,kagawa 761-0793, Japan, department of gastroenterology,kagawa university medical school,kagawa 761-0793, Japan, department for experimental medicine,institute for clinical and experimental medicine,prague 4, Czech Republic, laboratory of pathological and molecular pharmacology,osaka university of pharmaceutical sciences,takatsuki,osaka 569-1094, Japan, department of pharmacy,kagawa university hospital,kagawa 761-0793, Japan, department of pharmacology,kagawa university medical school,kagawa 761-0793, Japan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|